Effect of Alkyl Chain Length and Degree of Substitution on the Complexation of Sulfoalkyl Ether β-Cyclodextrins with Steroids
- 1 February 1997
- journal article
- Published by American Geophysical Union (AGU) in Journal of Pharmaceutical Sciences
- Vol. 86 (2) , 220-224
- https://doi.org/10.1021/js960236u
Abstract
This study was designed to test how the sulfoalkyl ether (SAE) modification of beta-cyclodextrin (beta-CD) affects the binding capacity of testosterone and progesterone, thereby enhancing their solubility. The SAE-beta-CD derivatives contain either sulfopropyl ether (SPE) or sulfobutyl ether (SBE) groups on the 2-, 3-, and 6-hydroxyl positions of the dextrose moieties. SAE-beta-CDs are a mixture of positional and regional isomers containing from one to as many as 12 SAE groups per CD. The effect of chain length and the degree of substitution on complexation behavior was investigated by the phase-solubility method. The results were compared with those obtained with beta-CD, where possible, and with hydroxypropyl-beta-CD (HP-beta-CD). To determine the effect of degree of substitution (DS) on the binding, mixtures of SAE-beta-CDs with multiple substitution levels and varying average degrees of substitution were studied as well as mixtures of SAE-beta-CDs that contained the same degree of substitution. Mixtures that contained SAE-beta-CDs of the same degree of substitution were isolated from the multiple substitution level mixtures by ion-exchange chromatography and purified for investigation. Unlike the parent beta-CD, linear increases in the apparent solubilities of testosterone and progesterone were observed, and the binding potentials were comparable to those of beta-CD or better. The results demonstrate that the binding potentials of the SAE-beta-CD derivatives were dependent on the guest molecule, the degree of substitution, and the alkyl ether chain length. Our previous study showed the inhibition of complexation by direct sulfonation of the beta-CD. However, in the present work, interferences with the charged sulfonate groups were avoided by repositioning them away from the cavity. Increasing the degree of substitution assisted in complex formation; however, its effects were limited. Reduction of the alkyl chain length, as in the case of SPE-beta-CD compared with SBE-beta-CD, decreased the complexation potential. This decrease in complexation potential was further suppressed with an increase in the number of substituents placed on the CD torus. Generally, the binding potential of SAE-beta-CD derivatives increased with increasing alkyl chain length. However, placement of more than an optimum number of SAE groups on the CD torus resulted in inhibition of complexation.Keywords
This publication has 24 references indexed in Scilit:
- Preliminary Safety Evaluation of Parenterally Administered Sulfoalkyl Ether β-Cyclodextrin DerivativesJournal of Pharmaceutical Sciences, 1995
- Complexation of Steroid Hormones with Cyclodextrin Derivatives: Substituent Effects of the Guest Molecule on Solubility and Stability in Aqueous SolutionJournal of Pharmaceutical Sciences, 1992
- Effect of various cyclodextrins on solution stability and dissolution rate of doxorubicin hydrochlorideInternational Journal of Pharmaceutics, 1992
- Interaction of naproxen with β-cyclodextrin in solution and in the solid stateInternational Journal of Pharmaceutics, 1992
- Use of 2-Hydroxypropyl-β-cyclodextrin as a Solubilizing and Stabilizing Excipient for Protein DrugsPharmaceutical Research, 1991
- Chemical Stabilization of a Vasoactive S-Nitrosothiol with Cyclodextrins Without Loss of Pharmacologic ActivityPharmaceutical Research, 1991
- Stabilization of mitomycins on complexation with cyclodextrins in aqueous acidic mediaInternational Journal of Pharmaceutics, 1989
- Inclusion complexation of metronidazole benzoate with β-cyclodextrin and its depression of anhydrate-hydrate transition in aqueous suspensionsInternational Journal of Pharmaceutics, 1984
- Inclusi on complexations of steroid hormones with cyclodextrins in water and in solid phaseInternational Journal of Pharmaceutics, 1982
- Interaction of Pharmaceuticals with Schardinger Dextrins IIIJournal of Pharmaceutical Sciences, 1964